Atossa Genetics - 13 Year Stock Price History | ATOS
Historical daily share price chart and data for Atossa Genetics since 2012 adjusted for splits and dividends. The latest closing stock price for Atossa Genetics as of June 13, 2025 is 0.83.
- The all-time high Atossa Genetics stock closing price was 2226.60 on March 19, 2013.
- The Atossa Genetics 52-week high stock price is 1.66, which is 100% above the current share price.
- The Atossa Genetics 52-week low stock price is 0.55, which is 33.7% below the current share price.
- The average Atossa Genetics stock price for the last 52 weeks is 1.08.
| Atossa Genetics Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 0.8004 | 0.9601 | 1.0300 | 0.5897 | 0.8305 | -12.03% |
| 2024 | 1.3002 | 0.9350 | 2.1000 | 0.8000 | 0.9441 | 7.28% |
| 2023 | 0.8097 | 0.5862 | 1.3500 | 0.5862 | 0.8800 | 66.51% |
| 2022 | 1.0330 | 1.7400 | 1.7400 | 0.5020 | 0.5285 | -66.97% |
| 2021 | 3.0766 | 0.9500 | 8.6200 | 0.9207 | 1.6000 | 68.42% |
| 2020 | 2.1099 | 1.5900 | 4.3500 | 0.7850 | 0.9500 | -39.49% |
| 2019 | 2.0714 | 1.1600 | 7.0700 | 1.1100 | 1.5700 | 53.92% |
| 2018 | 3.2993 | 3.2400 | 9.9912 | 0.9169 | 1.0200 | -67.68% |
| 2017 | 8.4707 | 17.0400 | 21.6972 | 2.7000 | 3.1560 | -81.35% |
| 2016 | 44.0299 | 64.8000 | 118.8000 | 15.7200 | 16.9200 | -70.63% |
| 2015 | 204.7952 | 252.0000 | 365.4000 | 57.6000 | 57.6000 | -77.62% |
| 2014 | 291.3921 | 408.6000 | 576.0000 | 147.6180 | 257.4000 | -38.36% |
| 2013 | 892.7325 | 684.0000 | 2226.6000 | 315.0000 | 417.6000 | -40.51% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.111B | $0.000B |
| Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $183.869B | 80.53 |
| Thermo Fisher Scientific (TMO) | United States | $156.785B | 18.97 |
| Edwards Lifesciences (EW) | United States | $44.517B | 29.19 |
| Alcon (ALC) | Switzerland | $43.958B | 29.71 |
| IDEXX Laboratories (IDXX) | United States | $42.376B | 48.70 |
| DexCom (DXCM) | United States | $32.486B | 50.21 |
| IQVIA Holdings (IQV) | United States | $27.529B | 15.42 |
| Mettler-Toledo (MTD) | United States | $24.694B | 29.37 |
| STERIS (STE) | Ireland | $23.846B | 26.26 |
| Waters (WAT) | United States | $20.803B | 29.35 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.964B | 0.00 |
| Hologic (HOLX) | United States | $14.534B | 15.79 |
| Sysmex ADR (SSMXY) | Japan | $10.991B | 31.18 |
| Penumbra (PEN) | United States | $9.813B | 77.02 |
| Masimo (MASI) | United States | $8.965B | 33.07 |
| Globus Medical (GMED) | United States | $8.150B | 19.42 |
| Glaukos (GKOS) | United States | $5.577B | 0.00 |
| Teleflex (TFX) | United States | $5.395B | 8.91 |
| TransMedics (TMDX) | United States | $4.838B | 105.18 |
| Integer Holdings (ITGR) | United States | $4.143B | 21.71 |
| PROCEPT BioRobotics (PRCT) | United States | $3.384B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.543B | 15.14 |
| Nihon Kohden (NHNKY) | Japan | $2.185B | 25.06 |
| Veracyte (VCYT) | United States | $2.090B | 29.33 |
| Elekta AB (EKTAY) | Sweden | $1.972B | 17.72 |
| Alphatec Holdings (ATEC) | United States | $1.662B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.393B | 0.00 |
| Artivion (AORT) | United States | $1.227B | 114.96 |
| Pulse Biosciences (PLSE) | United States | $1.088B | 0.00 |
| OPKO Health (OPK) | United States | $1.063B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.986B | 5.24 |
| Beta Bionics (BBNX) | United States | $0.845B | 0.00 |
| SiBone (SIBN) | United States | $0.778B | 0.00 |
| IRadimed (IRMD) | United States | $0.757B | 38.43 |
| RxSight (RXST) | United States | $0.580B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.572B | 8.90 |
| Mesa Laboratories (MLAB) | United States | $0.545B | 12.77 |
| Delcath Systems (DCTH) | United States | $0.545B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.528B | 0.00 |
| AxoGen (AXGN) | United States | $0.457B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.442B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.437B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.369B | 0.00 |
| NeuroPace (NPCE) | United States | $0.368B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.354B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.343B | 9.12 |
| ClearPoint Neuro (CLPT) | United States | $0.338B | 0.00 |
| 908 Devices (MASS) | United States | $0.258B | 0.00 |
| Neuronetics (STIM) | United States | $0.251B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.231B | 14.01 |
| Sight Sciences (SGHT) | United States | $0.218B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.216B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.189B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.184B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.176B | 0.00 |
| Inogen (INGN) | United States | $0.173B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.158B | 0.00 |
| CVRx (CVRX) | United States | $0.154B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.142B | 0.00 |
| Accuray (ARAY) | United States | $0.129B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.082B | 49.70 |
| EnVVeno Medical (NVNO) | United States | $0.077B | 0.00 |
| InspireMD (NSPR) | United States | $0.077B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.066B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| Spectral AI (MDAI) | United States | $0.054B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.052B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.028B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.54 |